CAPSTONE INVESTMENT ADVISORS, LLC - IONIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,164,175
+3.5%
15,450,0000.0%0.07%
-5.6%
Q2 2023$14,648,531
-10.6%
15,450,000
-13.9%
0.07%
-13.3%
Q1 2023$16,379,375
-1.7%
17,950,0000.0%0.08%
-31.4%
Q4 2022$16,659,844
-10.3%
17,950,000
-4.0%
0.12%
+8.0%
Q3 2022$18,571,000
+25.4%
18,700,000
+15.4%
0.11%
+55.6%
Q2 2022$14,812,00016,200,0000.07%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 127,800,000$128,518,0002.56%
WOLVERINE ASSET MANAGEMENT LLC 107,030,000$106,622,0001.15%
MACKAY SHIELDS LLC 24,472,000$24,283,0000.61%
SSI INVESTMENT MANAGEMENT LLC 6,945,000$6,865,0000.46%
ADVENT CAPITAL MANAGEMENT /DE/ 20,000,000$19,863,0000.36%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,500,000$15,433,0000.35%
Magnetar Financial LLC 16,700,000$16,606,0000.23%
CAMDEN ASSET MANAGEMENT L P /CA 4,300,000$4,249,0000.14%
CAPSTONE INVESTMENT ADVISORS, LLC 18,700,000$18,571,0000.11%
RWC Asset Management LLP 2,500,000$2,497,0000.08%
View complete list of IONIS PHARMACEUTICALS INC shareholders